Your browser doesn't support javascript.
International alliance and AGREE-ment of 71 clinical practice guidelines on the management of critical care patients with COVID-19: a living systematic review.
Amer, Yasser S; Titi, Maher A; Godah, Mohammad W; Wahabi, Hayfaa A; Hneiny, Layal; Abouelkheir, Manal Mohamed; Hamad, Muddathir H; ElGohary, Ghada Metwally; Hamouda, Mohamed Ben; Ouertatani, Hella; Velasquez-Salazar, Pamela; Acosta-Reyes, Jorge; Alhabib, Samia M; Esmaeil, Samia Ahmed; Fedorowicz, Zbys; Zhang, Ailing; Chen, Zhe; Liptrott, Sarah Jayne; Frungillo, Niccolò; Jamal, Amr A; Almustanyir, Sami A; Dieyi, Newman Ugochukwu; Powell, John; Hon, Katrina J; Alzeidan, Rasmieh; Azzo, Majduldeen; Zambrano-Rico, Sara; Ramirez-Jaramillo, Paulina; Florez, Ivan D.
  • Amer YS; Pediatrics Department and Clinical Practice Guidelines Unit, Quality Management Department, King Saud University Medical City, Riyadh, Saudi Arabia; Research Chair for Evidence-Based Health Care and Knowledge Translation, Deanship of Scientific Research, King Saud University, Riyadh, Saudi Arabia; A
  • Titi MA; Research Chair for Evidence-Based Health Care and Knowledge Translation, Deanship of Scientific Research, King Saud University, Riyadh, Saudi Arabia; Patient Safety Unit, Quality Management Department King Saud University Medical City, Riyadh, Saudi Arabia.
  • Godah MW; Faculty of Health Sciences, American University of Beirut, Beirut, Lebanon.
  • Wahabi HA; Research Chair for Evidence-Based Health Care and Knowledge Translation, Deanship of Scientific Research, King Saud University, Riyadh, Saudi Arabia; Family & Community Medicine Department, College of Medicine, King Saud University, Riyadh, Saudi Arabia.
  • Hneiny L; Saab Medical Library, University Libraries, American University of Beirut, Beirut, Lebanon.
  • Abouelkheir MM; Department of Clinical Pharmacy, College of Pharmacy, Misr International University, Cairo, Egypt.
  • Hamad MH; Division of Neurology, Pediatrics Department, King Khalid University Hospital, King Saud University Medical City, King Saud University, Riyadh, Saudi Arabia.
  • ElGohary GM; Internal Medicine and Clinical Hematology, Faculty of Medicine, Ain Shams University, Cairo, Egypt; University Oncology Center, University Medical City, King Saud University, Riyadh, Saudi Arabia.
  • Hamouda MB; Clinical Practice Guidelines Unit, INEAS l instance Nationale de l'évaluation et de l'accréditation en santé 7 Rue Ahmed Rami le belvedere 1001 Tunis-TUNISIA.
  • Ouertatani H; Clinical Pathways Unit, National Authority for Assessment and Accreditation in Healthcare (INEAS), Tunis, Tunisia.
  • Velasquez-Salazar P; Unidad de Evidencia y Deliberación para la toma de Decisiones (UNED), Faculty of Medicine, University of Antioquia, Medellín, Colombia.
  • Acosta-Reyes J; Department of Public Health, Universidad del Norte, Barranquilla, Colombia.
  • Alhabib SM; National Center for Evidence-Based Health Practice, Saudi Health Council, Riyadh, Saudi Arabia; King Abdullah Bin Abdulaziz University Hospital, Riyadh, Saudi Arabia.
  • Esmaeil SA; Research Chair for Evidence-Based Health Care and Knowledge Translation, Deanship of Scientific Research, King Saud University, Riyadh, Saudi Arabia.
  • Fedorowicz Z; Veritas Health Sciences Consultancy Ltd., Huntingdon, United Kingdom.
  • Zhang A; First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
  • Chen Z; First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
  • Liptrott SJ; Ente Ospedaliero Cantonale, via Gallino 12, 6500 Bellinzona, Switzerland.. Electronic address: sarahjayne.liptrott@eoc.ch.
  • Frungillo N; Oncology Unit, ASST Fatebenefratelli-Sacco, PO Fateberefratelli, Piazza Principessa Clotilde 3, 20121, Milan, Italy.
  • Jamal AA; Research Chair for Evidence-Based Health Care and Knowledge Translation, Deanship of Scientific Research, King Saud University, Riyadh, Saudi Arabia; Family & Community Medicine Department, College of Medicine, King Saud University, Riyadh, Saudi Arabia.
  • Almustanyir SA; Ministry of Health, Riyadh, Saudi Arabia.
  • Dieyi NU; Division of Community Health and Humanities, Memorial University, St. John's Newfoundland and Labrador, Canada.
  • Powell J; National Institute for Health and Care Excellence, London, UK; Nuffield Department of Primary Care Health Sciences, Radcliffe Observatory Quarter, Oxford OX2 6GG, UK.
  • Hon KJ; Division of Community Health and Humanities, Memorial University, St. John's Newfoundland and Labrador, Canada; Neuroscience, Mind, Brain, and Behavior, Harvard University, MA, USA.
  • Alzeidan R; Cardiac Sciences Department, College of Medicine, King Saud University, Riyadh, Saudi Arabia.
  • Azzo M; Pediatrics Emergency Department, The International Medical Center, Hail Street, 21451, Jeddah, Saudi Arabia.
  • Zambrano-Rico S; CES University, Medellín Colombia.
  • Ramirez-Jaramillo P; CES University, Medellín Colombia.
  • Florez ID; Department of Pediatrics, University of Antioquia, Medellin, Colombia; School of Rehabilitation Science, McMaster University, Hamilton, Canada. Electronic address: ivan.florez@udea.edu.co.
J Clin Epidemiol ; 142: 333-370, 2022 02.
Article in English | MEDLINE | ID: covidwho-1509964
ABSTRACT

OBJECTIVE:

We aimed to systematically identify and critically assess the clinical practice guidelines (CPGs) for the management of critically ill patients with COVID-19 with the AGREE II instrument. STUDY DESIGN AND

SETTING:

We searched Medline, CINAHL, EMBASE, CNKI, CBM, WanFang, and grey literature from November 2019 - November 2020. We did not apply language restrictions. One reviewer independently screened the retrieved titles and abstracts, and a second reviewer confirmed the decisions. Full texts were assessed independently and in duplicate. Disagreements were resolved by consensus. We included any guideline that provided recommendations on the management of critically ill patients with COVID-19. Data extraction was performed independently and in duplicate by two reviewers. We descriptively summarized CPGs characteristics. We assessed the quality with the AGREE II instrument and we summarized relevant therapeutic interventions.

RESULTS:

We retrieved 3,907 records and 71 CPGs were included. Means (Standard Deviations) of the scores for the 6 domains of the AGREE II instrument were 65%(SD19.56%), 39%(SD19.64%), 27%(SD19.48%), 70%(SD15.74%), 26%(SD18.49%), 42%(SD34.91) for the scope and purpose, stakeholder involvement, rigor of development, clarity of presentation, applicability, editorial independence domains, respectively. Most of the CPGs showed a low overall quality (less than 40%).

CONCLUSION:

Future CPGs for COVID-19 need to rely, for their development, on standard evidence-based methods and tools.
Subject(s)
Keywords
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Evidence-Based Medicine / Critical Care / COVID-19 Type of study: Prognostic study / Reviews / Systematic review/Meta Analysis Limits: Humans Language: English Journal: J Clin Epidemiol Journal subject: Epidemiology Year: 2022 Document Type: Article

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Evidence-Based Medicine / Critical Care / COVID-19 Type of study: Prognostic study / Reviews / Systematic review/Meta Analysis Limits: Humans Language: English Journal: J Clin Epidemiol Journal subject: Epidemiology Year: 2022 Document Type: Article